04948632 · Active · incorporated 22 years, 8 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Healthcare Series B+
A clinical-stage biopharmaceutical company developing a first-in-class oral p300/CBP inhibitor to treat multiple myeloma and other cancers.
See the complete cap table with every shareholder, founder tags, dilution across 45 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.